HomeINDV • LON
add
Indivior PLC
Previous close
GBX 699.50
Day range
GBX 714.00 - GBX 773.50
Year range
GBX 548.71 - GBX 1,770.00
Market cap
938.85M GBP
Avg Volume
381.79K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 298.00M | 1.71% |
Operating expense | 208.00M | 16.20% |
Net income | 9.00M | -83.33% |
Net profit margin | 3.02 | -83.61% |
Earnings per share | 0.32 | -25.84% |
EBITDA | 48.00M | -25.00% |
Effective tax rate | 70.97% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 320.00M | -21.95% |
Total assets | 1.47B | -24.97% |
Total liabilities | 1.67B | -14.48% |
Total equity | -205.00M | — |
Shares outstanding | 124.90M | — |
Price to book | -4.27 | — |
Return on assets | 6.83% | — |
Return on capital | 69.93% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 9.00M | -83.33% |
Cash from operations | -20.00M | 92.88% |
Cash from investing | 10.00M | 66.67% |
Cash from financing | 42.00M | 300.00% |
Net change in cash | 31.00M | 110.54% |
Free cash flow | -47.75M | 81.67% |
About
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Founded
Sep 26, 2014
Website
Employees
1,000
